News 2025
10.11.2025
New guidelines for the treatment of drug-resistant tuberculosis – shorter and better tolerated therapies
Individuals affected by drug-resistant tuberculosis (DR-TB) can now be treated in a significantly shorter and gentler manner. The tuberculosis guideline group for Germany, Austria, and Switzerland has revised its recommendations for treating this severe form of the disease. The revisions are based on the new guidelines issued by the World Health Organization (WHO) in 2025.
03.11.2025
Successful kick-off: Research Alliance Leibniz INFECTIONS launches new funding phase
On 29 and 30 October 2025, the members of the Research Alliance Leibniz INFECTIONS met for their 10th plenary meeting at the Research Centre Borstel, Leibniz Lung Centre (FZB). To mark the start of the new funding period, they presented the results of completed research projects and introduced new ones.
17.10.2025
Humanitarian Commitment for People in Ukraine
This week, the eighth shipment of essential medicines and medical instruments from Borstel set off for Ukraine. Since the beginning of the war, the FZB, together with the Rotary Clubs of Bargteheide and Stormarn, has been able to deliver aid worth well over €100,000 to Kharkiv in eastern Ukraine.
17.10.2025
Joint meeting: Northern Germany Meeting on Infection, Immunology & Inflammation
On Wednesday, October 8, 125 researchers from across Northern Germany gathered for the first Northern Germany Meeting on Infection, Immunology & Inflammation at Research Centre Borstel’s Manor House. The meeting was co-organized and co-hosted by “New Developments in Immunology, Inflammation, & Infection” (NDI³) – i.e. twelve PhD students from the FZB – and the NordInfect initiative.